The QualityStocks Daily Friday, May 6th, 2022

Today's Top 3 Investment Newsletters

QualityStocks(BBIG) $3.2900 +28.02%

MarketClub Analysis(FNKO) $21.2200 +26.91%

CBDWire(MCOA) $0.0008 +14.29%

The QualityStocks Daily Stock List

Stem Holdings, Inc. (STMH)

We reported earlier on Stem Holdings, Inc. (STMH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

consumers. It builds and partners with companies in manifold sectors of the marijuana market from distribution to hemp cultivation. The Company purchases, improves, and leases properties for use in the cannabis production, distribution, and sales industry in the Oregon. OTCQB-listed, Stem Holdings is based in Boca Raton, Florida.

Stem Holdings’ brands and partnerships comprise Incredibles; Reefer Distribution Co.; Supernatural; Cannavore, and PUL. Moreover, the Company’s brands and partnerships include TJ’s Gardens; GreenTFarms; Travis x James; Dose-Ology; G Pen, and Craft Extracts.

Pertaining to the Company’s Cultivation & Processing Properties, it has its 42nd Street facility. This large warehouse serves as a premier indoor cultivation facility just outside of Eugene, Oregon. The property has 22 grow rooms.

Regarding Stem Retail Properties, the Company builds boutique retail stores. TJ’s Provisions is its flagship marijuana dispensary, located in Eugene, Oregon. Also, Stem has its TJ’s on Willamette marijuana dispensary about one mile from the University of Oregon campus. Additionally, the Company has its TJ's on Powell. This is a 2,000 square foot retail storefront in Portland, Oregon.

Stem also has its Mulino Farm greenhouse cultivation facility. This property in Clackamas County has 12 commercial-grade greenhouses. Stem also has its Applegate Farms cultivation facility that consists of 40 acres in Jacksonville, Oregon.

The Company also has its TJ’s Wallis. This Eugene property will include two facilities. They will provide space for cultivation and processing. This location has a first-rate commercial kitchen for edibles production and grow rooms and an extraction lab. The Company’s TJ’s Las Vegas property (5,450 square feet) outside of Vegas will allow cultivation, processing, and distribution operations for the fast-growing Nevada cannabis market.

Stem Holdings, Inc. (STMH), closed Friday's trading session at $0.07, up 25.448%, on 1,444,682 volume with 133 trades. The average volume for the last 3 months is 1.445M and the stock's 52-week low/high is $0.0377/$0.5103.

Funko, Inc. (FNKO)

MarketBeat, Zacks, InvestorPlace, MarketClub Analysis, Trades Of The Day, The Street, Schaeffer's, BUYINS.NET, Daily Trade Alert, Market Intelligence Center Alert, Trading Concepts, TradersPro, StreetInsider, Marketbeat.com, StockMarketWatch, Market Intelligence Center, Barchart, InvestmentHouse and QualityStocks reported earlier on Funko, Inc. (FNKO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Funko, Inc. is a foremost pop culture consumer products company. Its goal is to provide consumers tangible ways to take their fandom offline. The Company designs, sources, and also distributes licensed pop culture products across manifold categories. These include vinyl figures, action toys, board games, plush, apparel, housewares, and accessories. Established in 2017, Funko is based in Everett, Washington. The Company’s shares trade on the NasdaqGS.

Funko sells its products to specialty retailers, mass-market retailers, e-commerce sites, as well as distributors. The Company also sells its products at specialty licensing and comic book shows, conventions, and exhibitions, and also via its e-commerce business.

Funko offers vinyl, blind-packed miniature, and action figures; plush products; accessories; and apparels, including t-shirts and hats. The Company also offers homewares, such as drinkware, party lights, and other home accessories.

Additionally, Funko offers bags, purses, and wallets, and board games. Funko offers its products under the Pop!, Loungefly, Mystery Minis, Paka Paka, 5 Star, SuperCute, and Pint Size Heroes brand names. Moreover, the Company licenses its properties under the classic evergreen, movie release, current TV, and current video game categories.

Funko offers its Exclusives. Examples from this category include “ Priya - Around The World”, “Scooby-Doo! (Flocked)”, and “10'' Huckleberry Hound - Hanna Barbera”. In addition, Examples include “10'' Pusheen With Pizza”, “Launchpad Mcquack”, “10'' Squirtle – Pokémon”, as well as “Velociraptor Clever Girl - Jurassic Park”.

Funko also offers its Best Seller Collectibles. These include 10” Coca-Cola Polar Bear; Tula-Pop Around the World; 10” Cap’n Crunch; America Cares Bear, and Boba Fett-Star Wars.

Funko, Inc. (FNKO), closed Friday's trading session at $21.22, up 26.9139%, on 5,486,961 volume with 47,780 trades. The average volume for the last 3 months is 5.469M and the stock's 52-week low/high is $15.28/$27.20.

Vinco Ventures (BBIG)

MarketClub Analysis, Schaeffer's, StocksEarning, QualityStocks, InvestorPlace, Trades Of The Day, BUYINS.NET, TradersPro, InvestorsUnderground and INO Market Report reported earlier on Vinco Ventures (BBIG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vinco Ventures Inc. (NASDAQ: BBIG) is a digital marketing and consumer products company. The firm operates as a product design, manufacturing, fulfillment and sales company in Europe, the Asia Pacific and North America.

Vinco Ventures Inc. has its headquarters in Bethlehem, Pennsylvania and was founded on July 18, 2017. Before changing its name in November 2020, the firm was known as Edison Nation Inc. The firm serves consumers in the United States as well as internationally.

Vinco Ventures Inc. operates through the following tools: Pop Nation and Honey Badger Media. The former’s process of proprietary monetization changes traffic to dollars while the latter is a full service content monetization firm that is focused on brand specific messaging and that also designs digital campaigns from creation to monetization. Additionally, the firm has various internally developed brands which work as a launchpad for new items. The brands include Ngenious Fun, Barkley Lane, Smarter Specs, Eco Quest, Trillion Trees, Sol and Salud, Lily and Grey, Best Party Concepts, Uber Mom, Pirasta and Cloud B.

Vinco Ventures Inc. offers late stage inventions, proof of concept prototypes and sketches, and also develops and manufactures products for other brands in the theme park and entertainment industries.

As of December 2020, Vinco Ventures Inc. had entered into an agreement with OPTEC International Inc. to produce and distribute their health and wellness products on live shopping and digital commerce. This collaboration would help expand the reach of both companies, which would be good for their growth, as well as their stock prices.

Vinco Ventures (BBIG), closed Friday's trading session at $3.29, up 28.0156%, on 139,294,852 volume with 320,050 trades. The average volume for the last 3 months is 137.869M and the stock's 52-week low/high is $1.94/$12.49.

Arena Minerals Inc. (AMRZF)

We reported earlier on Arena Minerals Inc. (AMRZF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Arena Minerals Inc. (OTC: AMRZF) (CVE: AN) is a mineral exploration firm that is focused on acquiring, exploring for and developing mineral properties.

The firm has its headquarters in Toronto, Canada and was incorporated in 1995, on August 29th. Prior to its name change in December 2013, the firm was known as Antofagasta Gold Inc. It operates as part of the metal ore mining industry and serves consumers around the globe, with a focus on South America and Canada.

The company is focused on acquiring properties in South America. It mainly explores for copper and lithium and has assets in Chile and Argentina. The company’s projects include the Atacama Copper Property in Chile as well as other projects in Argentina.

The enterprise holds interest in the Atacama copper property which covers an area of roughly 7,000 hectares and is situated in the Antogasta region in Chile. It also owns the Antofalla lithium brine project which is made up of 4 claims that cover about 6,000 hectares. These claims are situated in the Salar de Antofalla region, which is found south of the Antofalla project owned by Albemarle Corp. The enterprise’s brine processing technology uses reagents which have been derived from its project with its aim being to produce battery grade lithium products.

The company recently approved a new comprehensive development work program, which will be focused on the expansion of its lithium brine resource estimate and establishing an ideal route for producing high purity lithium products.

Arena Minerals Inc. (AMRZF), closed Friday's trading session at $0.38645, off by 2.902%, on 420,879 volume with 76 trades. The average volume for the last 3 months is 420,879 and the stock's 52-week low/high is $0.07985/$0.60.

Kubient Inc. (KBNT)

StockRockandRoll, PennyStockLocks, Penny Stock 101, StreetInsider, Trades Of The Day, StockWireNews, StockStreetWire, Small Cap Firm, MarketBeat and Fierce Analyst reported earlier on Kubient Inc. (KBNT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kubient, Inc. (NASDAQ: KBNT) is a technology firm that is focused on the development of a cloud-based software platform for the digital advertising industry.

The firm has its headquarters in New York and was incorporated in May 2017 by Paul Roberts. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe, with a focus on consumers in Russia and United States.

The company’s objective is to transform the digital advertising industry to marketing that’s audience based. Its next generation cloud-based infrastructure allows for efficient marketplace liquidity for sellers and buyers of digital advertising.

The enterprise’s products include a platform for real-time trading of digital, programmatic advertising known as the Audience Cloud. This independent platform is an open and flexible marketplace which facilitates automated transaction execution and intelligent-decision making, enabling publishers and advertisers to connect with, reach and monetize their audiences. It also allows sellers and buyers to transact with confidence in a fraud-free, honest and open environment. This solution also demands transparency and is available in any channel, including digital out-of-home, mobile, desktop and connected devices, as well as in any format whether audio, display, video and native.

The firm is focused on its growth strategy and vetting multiple acquisition targets on the mergers and acquisitions front in an effort to find companies which can add accretive value to it. This will help create shareholder value and encourage more investments into the firm, which will positively influence its growth.

Kubient Inc. (KBNT), closed Friday's trading session at $0.882751, off by 5.0805%, on 53,940 volume with 304 trades. The average volume for the last 3 months is 53,940 and the stock's 52-week low/high is $0.87/$6.10.

Landos Biopharma (LABP)

MarketBeat reported earlier on Landos Biopharma (LABP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Landos Biopharma Inc. (NASDAQ: LABP) is a clinical-stage biopharmaceutical firm that is focused on the discovery and development of oral therapeutics for autoimmune illnesses.

The firm has its headquarters in Blacksburg, Virginia and was incorporated in January 2017 by Josep Bassaganya-Riera. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers around the globe.

The company uses its Lance platform to identify new therapeutic targets based off of predictions of immune-metabolic function and develops therapeutic candidates to engage said targets in areas of unmet medical needs.

The enterprise’s product pipeline comprises of a small molecule oral LANCL2 pathway agonist dubbed LABP-111, for the treatment of type 1 diabetes and non-alcoholic steatohepatitis; an oral and small molecule NLRX1 pathway agonist known as LABP-73, for the treatment of chronic obstructive pulmonary disease and asthma; and an oral PLXDC2 agonist dubbed LABP-69, for the treatment of rheumatoid arthritis and diabetic nephropathy. It also develops a systematically bioavailable and orally-active small molecule candidate dubbed LABP-104, which targets the LANCL2 agonist, for the treatment of rheumatoid arthritis and systemic lupus erythematosus. In addition to this, the enterprise develops its omilancor candidate for the treatment of eosinophilic esophagitis, Crohn’s disease and ulcerative colitis.

The firm is currently refining its clinical development roadmap, advancing its development programs and pursuing its promising therapies. The success and approval of its candidates will not only benefit patients with certain indications and help create shareholder value but also bolster the firm’s growth.

Landos Biopharma (LABP), closed Friday's trading session at $0.7797, off by 6.6563%, on 116,942 volume with 725 trades. The average volume for the last 3 months is 116,942 and the stock's 52-week low/high is $0.7001/$16.17.

Luna Innovations (LUNA)

OTCPicks, MarketBeat, SmarTrend Newsletters, StockMarketWatch, Greenbackers, PennyOmega, QualityStocks, Zacks, DrStockPick, HotOTC, CRWEWallStreet, BestOtc, MicrocapVoice, CRWEPicks, CRWEFinance, Marketbeat.com, PennyStocks24, PennyToBuck, StockHotTips, StreetInsider, Stock Beast, Stock Rich, Investopedia, Street Insider, Flagler Financial Group, The Lotto Pick, The Street, Wall Street Resources, Wealth Insider Alert, CoolPennyStocks and Penny Stocks Profile reported earlier on Luna Innovations (LUNA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Luna Innovations Inc. (NASDAQ: LUNA) is an advanced optical technology firm that is focused on the development, manufacture and marketing of fiber optic measurement, test and control products.

The firm has its headquarters in Roanoke, Virginia and was incorporated in July 1990 by Kent A. Murphy. It operates as part of the scientific and technical instruments industry, under the technology sector. The firm serves consumers in the United States.

The enterprise provides optical test and measurement products, which include optical backscatter reflectometers, optical vector analyzers and tunable lasers and Hyperion sensing solutions. It also offers polarization control products, including instruments, modules and components to manage, control and measure polarization and group delay in fiber optic networks; temperature and strain sensing products; single frequency lasers; tunable lasers; and ODiSI sensing solutions, which offer distributed temperature and strain measurements. It also offers Terametrix terahertz imaging and gauging products which offer multi-layer and precise single thickness, basis weight, density and caliper thickness measurements. The enterprise mainly markets its fiber optic measurement, test and control products directly to testing laboratories, defense agencies, telecommunications firms, researchers, government system integrators, original equipment manufacturers, strategic partners and distributors. It also markets them through independent sales representatives, value added resellers and technical sales engineers.

The company recently announced its latest financial results, which show increases in its revenues. It remains focused on its strategy and enhancing its global leadership position in fiber optic technology. This will help extend the company’s consumer reach globally and help bring in more revenues and investments, which will bolster its growth.

Luna Innovations (LUNA), closed Friday's trading session at $5.23, off by 3.3272%, on 143,417 volume with 2,572 trades. The average volume for the last 3 months is 143,417 and the stock's 52-week low/high is $5.11/$12.99.

NeuBase Therapeutics (NBSE)

TradersPro, MarketBeat, Zacks, StreetInsider and MarketClub Analysis reported earlier on NeuBase Therapeutics (NBSE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NeuBase Therapeutics Inc. (NASDAQ: NBSE) (FRA: O7PA) (BMV: NBSE) is a pre-clinical stage biopharmaceutical firm that is engaged in developing therapies for the treatment of rare genetic illnesses and cancers caused by mutations.

The firm has its headquarters in Pittsburgh, Pennsylvania and was incorporated in 2009, on August 4th by Dietrich A. Stephan. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has six companies in its corporate family and serves consumers in the United States.

The company’s Patrol platform develops drugs for rare illnesses like Familial Parkinson’s disease, Myotonic Dystrophy and Huntington’s Disease. The platform is comprised of new peptide-nucleic acid antisense oligonucleotide technology combined with delivery shuttles, which are used to develop gene silencing therapies. The company remains focused on addressing the needs of patients whose indications currently have no therapeutic options.

The enterprise’s product pipeline comprises of a Patrol-enabled therapeutic treatment dubbed NT0300, which has been designed to target the KRAS mutated gene. It also develops an enabled anti-gene for myotonic dystrophy type 1 known as NT0200. In addition to this, the enterprise develops an anti-gene for Huntington’s disease dubbed NT0100.

The company remains focused on advancing its IND-enabling studies for its myotonic dystrophy type 1 program. The success and approval of this formulation for use in treating this rare illness will not only benefit patients with this indication but also bring in more revenues as well as investors into the company, which will be good for its growth.

NeuBase Therapeutics (NBSE), closed Friday's trading session at $1.04, off by 4.8577%, on 55,246 volume with 430 trades. The average volume for the last 3 months is 55,246 and the stock's 52-week low/high is $1.00/$5.70.

MiMedx Group (MDXG)

MarketClub Analysis, Schaeffer's, InvestorPlace, Streetwise Reports, MarketBeat, The Street, StreetInsider, INO.com Market Report, Market Intelligence Center Alert, QualityStocks, TradersPro, Barchart, StockMarketWatch, Zacks, StocksEarning, Stock Market Watch, TopPennyStockMovers, Marketbeat.com, TraderPower, Wall Street Resources, BUYINS.NET, Daily Trade Alert, Early Investing, Goldman Small Cap Research, GorillaTrades, MissionIR, VectorVest, AllPennyStocks, Top Pros' Top Picks and Investing Futures reported earlier on MiMedx Group (MDXG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MiMedx Group Inc. (NASDAQ: MDXG) is focused on the development and distribution of placental tissue allografts to different sectors of healthcare.

The firm has its headquarters in Marietta, Georgia and was incorporated in 1985, on July 30th. It operates as part of the medical equipment and supplies manufacturing industry, under the healthcare sector. The firm has two companies in its corporate family and serves medical industries around the globe.

The company processes human placental tissues using its proprietary and patented Purion process to develop allografts that retain the tissue’s inherent regulatory proteins and biological properties. In addition to terminal sterilization, its processing method utilizes aseptic processing techniques.

The enterprise’s products include a semi-permeable protective barrier allograft dubbed AmnioFix, which is used in surgical recovery applications; a semi-permeable protective barrier membrane product known as EpiFix, which is used to treat chronic wounds like pressure ulcers, venous leg ulcers and diabetic foot ulcers; and AmnioCord and EpiCord, which are dehydrated human umbilical cord allografts utilized in providing a protective environment for the healing process. The enterprise also develops a micronized form of Amniofix dubbed mdHACM, which comes in powder form and a semi-permeable protective barrier allograft dubbed Amnioburn, to treat full-thickness and partial-thickness burns.

The company remains focused on increasing the adoption of its Purion tissue technologies and advancing research initiatives which expand the scientific foundation of its biologics portfolios and enable its commercial strategy. This will positively influence its growth as well as investments into the company.

MiMedx Group (MDXG), closed Friday's trading session at $3.6, off by 7.9284%, on 748,717 volume with 7,691 trades. The average volume for the last 3 months is 748,717 and the stock's 52-week low/high is $3.59/$15.99.

Industrial Nanotech Inc. (INTK)

Stock Guru, UndiscoveredEquities, OTCPicks, The Cervelle Group, Industrial Nanotech, PennyTrader Publisher, Stock Stars, TheStockWizards.net, QualityStocks, Stocks That Move, MadPennyStocks, PennyInvest, Greenbackers, FeedBlitz, CoolPennyStocks, HotOTC, PennyStockVille, BullRally, SmallCapVoice, WiseAlerts, StockEgg, StockGuru, StockRich, The Cevelle Group and Pumps and Dumps reported earlier on Industrial Nanotech Inc. (INTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and product development leader, today released a shareholder update from its CEO/CTO Stuart Burchill to further communicate the significance of its new Pemex project. Among facts and statistics to provide shareholders a more thorough understanding, Burchill clarified that Pemex is Mexico’s oil and gas company and, in 2021, had reported assets of US$96.8 billion and revenue of US$44.3 billion. “Reinstating our working relationship with Pemex on this first tank project is extremely significant and has given us the opportunity to restart all of these projects and more,” stated Burchill. “We project $5-10 million in revenue from Pemex in the remainder of 2022 and we project that Pemex will be one of our larger revenue streams in 2023, exceeding our previous 2014 projections of $67 million U.S. annually.”

To view the full press release, visit https://ibn.fm/S0eFB

About Industrial Nanotech Inc.

Industrial Nanotech is a global nanoscience solutions and product development leader. For more information about the company, visit www.Industrial-Nanotech.com.

Industrial Nanotech Inc. (INTK), closed Friday's trading session at $0.018, off by 10%, on 24,868,772 volume with 903 trades. The average volume for the last 3 months is 24.869M and the stock's 52-week low/high is $0.0001/$0.0523.

Royal Gold Inc. (RGLD)

TopStockAnalysts, Streetwise Reports, StreetAuthority Daily, InvestorPlace, TradingAuthority Daily, The Street, Daily Wealth, MarketBeat, Top Pros' Top Picks, StreetInsider, Daily Trade Alert, SmarTrend Newsletters, All about trends, TheStockAdvisor, Energy and Capital, Zacks, Money Morning, MarketClub Analysis, The Growth Stock Wire, TheStockAdvisors, Dividend Opportunities, Trades Of The Day, Wyatt Investment Research, Marketbeat.com, Wealth Daily, Barchart, Lebed.biz, Investor Update, Uncommon Wisdom, Daily Profit, Money and Markets, Investment U, National Inflation Association, TradingMarkets, The Online Investor, Traders For Cash Flow, Stockhouse, Schaeffer's, Greenbackers, Forbes, Outsider Club, Kiplinger Today, Weekly Wizards, QualityStocks, Market Intelligence Center Alert, Trade of the Week, BestChartNow, Investing Futures, Wealth Insider Alert, Dynamic Wealth Report, AllPennyStocks, ChartAdvisor, FNNO Newsletters, Bourbon and Bayonets, GorillaTrades, Hit and Run Candle Sticks, One Hot Stock, Inside Investing Daily, The Best Newsletters, Investopedia, StocksEarning, Stocks That Move, Market Authority, Market FN, Stansberry Research, Short Term Wealth, Profits Run, PowerRatings Stocks, Penny Stock Chaser and INO.com Market Report reported earlier on Royal Gold Inc. (RGLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The investment demand for gold is increasing as investors flock back to gold, which is driving the metal’s price even higher. The precious metal’s current performance began in 2015 when the Fed initiated its rate-hike cycle. During the years since, gold has gained significantly, with its best gain extending to 96% in August 2020.

Weakening stock markets also bolster investment demand for gold by boosting its use in the diversification of portfolios. This is because the precious metal rallies during stock-market selloffs, making it a good portfolio stabilizer. Investment buys then accelerate the upside momentum of gold, which helps attract even more investors.

Geopolitical fears that increased earlier in February of this year also boosted gold’s rally, after Russia invaded Ukraine. The price of gold after the invasion had increased to $1,899. This surge continued well into March, with the price rising to $2051, driven mainly by speculators flooding into gold futures and increasing uncertainty following Russia’s declaration of war against Ukraine.

Inflation is also eroding purchasing power, which has prompted many to rush to gold as a safe haven asset. While high levels of inflation and rate hikes by the Federal Reserve are bearish for overvalued stock prices, they are very bullish for gold. Investors usually add gold to stabilize their bleeding portfolios when stocks get weaker in bear markets.

Historically speaking, rate hikes by the Fed have always been bullish for gold. The primary reason why this particular precious metal thrives during these cycles is because it’s bearish for stocks. Gold performs best when it enters these cycles when they’re gradual and relatively low.

The combined holdings of physical gold bullion of the dominant and leasing IAU iShares Gold Trust and American GLD SPDR Gold Shares gold-exchange-traded funds mirror global investment flows into gold. They reveal if American stock-market capital is flowing out of or into gold. When the precious metal is moving, IAU+GLD holdings dominate quarterly investments into gold.

However, investment capital inflows into gold across the globe aren’t easy to track. To address this, GLD+IAU holdings track comprehensive global demand and supply data for gold in nearly every quarter, making it a near real-time window into how investment demand for gold is faring. Every quarter, the World Gold Council also publishes a report on this data.

Strong investment demand for gold is expected to persist for years, given the raging inflation and weaker stock prices. The long-term winners are likely to be companies such as Royal Gold Inc. (NASDAQ: RGLD) whose stocks could soar as the price of physical gold rises.

Royal Gold Inc. (RGLD), closed Friday's trading session at $130.14, off by 1.8404%, on 468,753 volume with 13,950 trades. The average volume for the last 3 months is 465,102 and the stock's 52-week low/high is $92.01/$147.70.

Rivian Automotive Inc. (RIVN)

Kiplinger Today, InvestorPlace, The Street, QualityStocks, Schaeffer's, Trades Of The Day, MarketBeat, The Online Investor, StocksEarning and Daily Trade Alert reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

As the fight against climate change continues and the use of fossil fuels is phased out, the adoption of electric vehicles is growing. However, while most states are now on board with the idea of EVs, this wasn’t the case a couple of years ago. Experts believe that various cultural, political and economic factors have helped create the conditions for this shift. We discuss some of these factors below.

Lower costs

Electric cars need rechargeable and energy-dense batteries to function. The prices of these vehicles were very high, especially before the price of li-ion battery packs reduced significantly.

Despite this reduction in battery prices, however, electric vehicles remain a bit more expensive than gas cars. Over the long term, electric cars are cheaper than their gas-guzzling counterparts.

Growing market

Only a handful of automakers were manufacturing electric cars in the last decade. This figure has increased greatly these last few years, with companies such as Ford entering the market and producing electric vehicle models to help meet the high demand for these cars.

Some companies, including General Motors, Volvo and Jaguar, are even promising to sell only electric models in the coming years.

Variety in the market

A decade ago, there were only eight electric car models to choose from in the United States. This year, the number of electric vehicle models will increase to 100. Consumers are waiting for the type of model that meets their needs and their budget, which has increased demand considerably.

Increase in global competitiveness

Europe and China are at the forefront of the switch to electric vehicles, making up more than 80% of global electric car sales in 2021. This is unlike in the past when electric vehicles were niche products for a select few in America.

Having a strong electric vehicle presence has become crucial for auto manufacturers, especially as more countries strive to meet their climate targets and phase out fossil fuel use.

Changing public attitudes

A recently conducted poll found that more than 50% of voters in America were in favor of making all vehicles electric by 2030. Almost half of the individuals surveyed were also considering purchasing an electric car in the next couple of years.

This shows that most individuals have began grasping that the era of gas-powered vehicles may soon come to an end.

However, the shift to using electric cars won’t be smooth, what with barriers like a lack of charging infrastructure and uncertain policy landscape. Nevertheless, sector players such as Rivian Automotive Inc. (NASDAQ: RIVN) are doing what they can to avail different EV models while other stakeholders, including state and federal agencies, are doing their part too. Sooner rather than later, the industry will take off as those different efforts converge.

Rivian Automotive Inc. (RIVN), closed Friday's trading session at $28.79, off by 6.252%, on 20,691,037 volume with 188,800 trades. The average volume for the last 3 months is 20.32M and the stock's 52-week low/high is $28.71/$179.4699.

The QualityStocks Company Corner

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton (NASDAQ: CPTN) recently became a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II. The program is designed to advance STEM education and contribute to groundbreaking work within the autonomous driving space. “As a leading innovator in the LiDAR space, Cepton has always been committed to becoming the bridge between cutting-edge science and the automotive industry. Autonomous driving and its great enabler – LiDAR technology – are ready to take over the mobility space as the innovative technology makes strides in terms of decreasing costs and improving commercial potential. Cepton appears determined to be a visible part of that landscape,” a recent article reads. Dr. Jun Pei, CEO of Cepton, said, “LiDAR is going mainstream with it being deployed in advanced driver assistance systems (‘ADAS’) in everyday consumer vehicles to be available in the next few years. This sensor technology is not only capable of improving vehicle safety but also critical in enabling higher levels of autonomy. We are dedicated to helping proliferate the benefits of LiDAR technology by focusing on its mass-market scalability with our proprietary Micro Motion Technology (MMT(R))….” To view the full article, visit https://ibn.fm/pBmDx

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Friday's trading session at $2.86, up 0.704225%, on 132,744 volume with 1,247 trades. The average volume for the last 3 months is 132,744 and the stock's 52-week low/high is $2.78/$80.16.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands available to U.S. customers, namely ON! and Zyn,” a recent article reads. The human study NIC-H22-1 is expected to build on the successes of the company’s animal studies, which have proven the technology’s effectiveness in promoting faster absorption, higher peak absorption, and greater overall quantities of nicotine, on average, in the blood than concentration-matched control formulations. “In 2021, the company announced its oral nicotine absorption study, NIC-A21-1, revealing that DehydraTECH-oral nicotine delivery peaked in the bloodstream 10x to 20x faster than controls, and peak levels achieved were up to 10x higher than controls. ‘Performance gains of this magnitude could be of great significance in enabling the oral pouch product category to offer improved nicotine satiety and effectiveness, with a goal of one day rendering pulmonary administration practices like smoking and vaping as obsolete,’ Lexaria CEO Chris Bunka said of last year’s outstanding results.” To view the full article, visit https://cnw.fm/OZuaK

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Friday's trading session at $2.85, up 4.7794%, on 29,970 volume with 138 trades. The average volume for the last 3 months is 29,961 and the stock's 52-week low/high is $2.525/$12.50.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

When the current wave of marijuana legalization hadn’t fully taken root around the country, concerns about impaired driving mainly focused on alcohol. Today, impaired driving can be due to alcohol, cannabis and, in some few cases, medications. For a police officer looking for impaired drivers, there is a growing challenge to distinguish cannabis impairment from impairment caused by alcohol consumption. This is because there is no agreement about how much THC, the cannabis compound responsible for making users high, is sufficient to cause a driver to be impaired. Additionally, impaired drivers exhibit the same signs, such as swerving while driving, delayed reactions while at traffic intersections, driving too slowly or too fast, and so on. As the consumption of marijuana becomes more mainstream, opportunities may arise for companies such as Advanced Container Technologies Inc. (OTC: ACTX), which don’t deal in marijuana directly but rather meet the needs of people in the “plant-touching” line of business. These companies have every reason to support efforts to keep impaired drivers off the road.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Friday's trading session at $1, up 1.5228%, on 402 volume with 5 trades. The average volume for the last 3 months is 402 and the stock's 52-week low/high is $0.66/$4.55.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to satisfy demand in the state. “The debut marks RWB’s line expansion into the higher-margin live resin vapes segment and also represents its inaugural product in Michigan beyond the popular distillate vape products. The company is committed to releasing many more products in the future,” a recent article reads. “Red White & Bloom expects PV Live Resin to become popular with consumers owing to the trust they have in the PV brand. With the PV Live Resin, which was previously only available in Oklahoma and California, RWB aims to tap into the growing U.S. live resin market. According to Greentank, live resin sales increased 86% between 2020 and 2021. But RWB holds that this growth is only the beginning. ‘We believe that this is just the tip of the iceberg for the live resin opportunity since so many new cannabis consumers are totally unfamiliar with live resin and migrate to it once they learn more about cannabis and discover live resins’ many advantages,’ company CEO Brad Rogers said.” To view the full article, visit https://cnw.fm/vhObr

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.

Brands

Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.

Cultivation

Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.

Footprint

Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 (https://nnw.fm/f09ZL). Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (https://nnw.fm/vObW6).

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Friday's trading session at $0.18, up 2.8571%, on 146,061 volume with 42 trades. The average volume for the last 3 months is 146,061 and the stock's 52-week low/high is $0.157/$1.21.

Recent News

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Pharma (OTCQB: SILO) recently announced an agreement with Frontage Laboratories, a contract research organization, for an Investigational New Drug (“IND”)-enabling pharmacokinetic study. “Silo merges traditional therapeutics with psychedelic research to relieve patients suffering from PTSD, Alzheimer’s, Parkinson’s, and other rare neurological disorders,” a recent article reads. “Frontage will study Silo’s central nervous system peptide, SPU-16, ’a potential new treatment for multiple sclerosis and other conditions,’ and the company’s joint homing peptide, SPU-21, used for treating arthritogenic processes, which, according to Silo Pharma CEO Eric Weisblum, could, ‘enhance the therapeutic effect of current and future therapeutics while decreasing potential systemic toxicity…. They may be used to treat both central nervous system and autoimmune diseases.’” To view the full article, visit https://ibn.fm/0ajIv

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Friday's trading session at $0.1675, up 2.9502%, on 7,749 volume with 5 trades. The average volume for the last 3 months is 7,749 and the stock's 52-week low/high is $0.12/$0.31.

Recent News

Hero Technologies Inc. (OTC: HENC)

The QualityStocks Daily Newsletter would like to spotlight Hero Technologies Inc. (OTC: HENC).

Hero Technologies (OTC: HENC), a cannabis company, is ideally poised as a new report revealed that states that have legalized recreational marijuana collected an estimated $3.7 billion in tax revenue last year. “That news bodes well for savvy players in the legal cannabis space, including Hero Technologies, as states are often eager to support revenue sources,” a recent article reads. “Hero Technologies is looking to leverage its cannabis expertise in more of those states. The company currently has a majority stake in BlackBox Systems and Technologies LLC, which has been operating legally in Michigan as a medical caregiver. HENC is aggressively pursuing an expansion of its cultivation and dispensary operations in Colorado through Mile High Green LLC, a wholly owned subsidiary. The company is also looking to move into Massachusetts through an additional wholly owned subsidiary, MassCannabis LLC. These states are in the top-six cannabis markets in the United States. While California tops the list, Colorado comes in at number three, reporting a $2.5 billion market, with Michigan following in the number four spot, showing a $1.4 billion market. Massachusetts ranks number six, with a market of $1.2 billion.” To view the full article, visit https://cnw.fm/W13Yh

Hero Technologies Inc. (OTC: HENC) is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries that make the organization a multi-state operator (MSO).

The company was founded in 2004 and is headquartered in Dover, Delaware.

Portfolio

The company holds the majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation firm focused on providing optimal conditions to enhance photosynthesis and cultivation. Hero Technologies is planning expansion in cultivation and dispensary operations in Colorado through wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.

Hero Technologies also owns and operates HighlyRelaxing.com under Highly Relaxing LLC and recently acquired the assets of V Brokers LLC, now operating as Veteran Hemp Co. at VeteranHempCo.com.

BlackBox Systems and Technologies LLC

BlackBox Systems and Technologies LLC markets a proprietary cannabis aeroponic cultivation system designed for the large-scale production of top-shelf cannabis products. BlackBox offers the optimal conditions to enhance photosynthesis and promote the cultivation of large flowering plants. The system’s dry room, process room and secure storage were designed for precise control through each phase of the cannabis lifecycle. Weekly harvests are achieved using 13 separate BlackBox systems in independent modules.

The system provides a series of key benefits, including:

  • High-pressure nutrient delivery, with no nutrient or PH deficiencies
  • Sterile, 100% nutrient solution
  • Drain to Waste (no reuse of wastewater)
  • Low water usage (1 gallon per plant per day)
  • Constant PH and EC in reservoirs
  • Modular design (1 to 100 pods in any configuration)
  • Innovative proprietary engineering
  • Minimal cleanup
  • Media-less growing, suspended in the air, with no media waste
  • No pesticides

Highly Relaxing LLC

Highly Relaxing LLC is an emerging Henderson, Nevada-based operation dedicated to providing customers with honestly labeled, high-quality hemp-derived CBD products. Its current offerings include a topical CBD cream that provides localized relief from potential discomfort.

Veteran Hemp Co.

Veteran Hemp Co.’s mission is to provide a quality, consistent and delicious product for Americans looking to enjoy the hemp smoking experience. Its product is brought in by only the finest farming operations delivering the best genetics. Veteran Hemp Co. has its own custom harvest plans, drying facilities and all of the logistics that fall between. Veteran Hemp Co. prides itself on being a veteran-approved company.

Market Outlook

The global legal cannabis market is anticipated to reach $84 billion by 2028, expanding at a CAGR of 14.3% from 2021 to 2028. The driving factor for this forecast expansion is the increasingly widespread legalization of cannabis for medical and recreational use. Recreational use accounted for 60.3% of industry revenue in 2020.

North America provided the largest revenue share in the cannabis market, accounting for 91.1% of the global market in 2020. Due to the early legalization of medical and recreational cannabis in the region, the customer pool has increased exponentially (https://nnw.fm/snpHh).

The global CBD market was valued at $2.8 billion in 2020 and is expected to grow at a CAGR of 21.2% and reach $13.4 billion by 2028. North America is considered the most progressive region for cannabis and its derived products, with the highest number of CBD companies being based on the continent. The B2B (business to business) segment dominates the CBD industry, accounting for the largest revenue share at 59.6% in 2020 (https://nnw.fm/cGxXQ).

With its vertically integrated business model and development into a multi-state operator across multiple sectors of the cannabis industry, Hero Technologies is uniquely positioned to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers.

Management Team

Gina Serkasevich, CPA, CMA, is the Chief Executive Officer, Treasurer and Secretary of the Hero Technologies. She previously worked for Holloman Corporation as its Director of Finance beginning in June 2012 and was appointed Chief Financial Officer of Holloman Energy Corporation in August 2014. She has more than 30 years of domestic and international corporate accounting and finance experience. She served as U.S. Controller for EFLO Energy Inc., a company focused on the acquisition, exploration and development of oil and gas assets in North America. Prior to 2012, Ms. Serkasevich worked in the oil and gas tanker transportation industry as a Regional Financial Manager for AET Inc. Limited (2011-2012), as a Financial Consultant for OSG Ship Management Inc. (2009-2011) and as a Financial Controller/CFO for Stena Bulk LLC (1998-2008). During her 11-year tenure at Stena Bulk LLC, she established the financial, accounting and reporting requirements for its new joint ventures and tanker pools with Sonanagol USA and held the Company Secretary position on both of those companies’ boards of directors.

Dan McCarthy is the company’s Corporate Development Manager. He has spent more than 12 years in the institutional investment community, holding various investment banking and private equity executive roles. Thus far, he has been a part of over $1 billion in transactional value ranging from debt and equity to acquisitions and diversities throughout his career. Mr. McCarthy’s most recent role was Managing Director at Petro Capital, a Dallas-based private equity and investment bank. He began his career working for a private international consulting firm based in Washington, D.C., helping corporations and funds expand into non-G7 countries utilizing World Bank financing. He is also a graduate of the University of Kansas School of Business and completed the Mergers and Acquisitions program at the New York Institute of Finance.

James Rowland is Hero Technologies’ Marketing Advisor and an expert in marketing and e-commerce. He has held many high-level marketing and business-related roles. He is the Founder and current CEO of PerfectCheckout.com and the current Business Development Specialist at Fulfillment.com. Mr. Rowland has held multiple high-level positions throughout his career, which have provided him with the experience needed to bring success-backed marketing leadership skills to his current role with the company.

Hero Technologies Inc. (HENC), closed Friday's trading session at $0.047, up 21.6356%, on 11,776 volume with 6 trades. The average volume for the last 3 months is 11,776 and the stock's 52-week low/high is $0.032/$0.0995.

Recent News

Kronos Advanced Technologies Inc. (OTC: KNOS)

The QualityStocks Daily Newsletter would like to spotlight Kronos Advanced Technologies Inc. (OTC: KNOS).

  • “Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article
  • Kronos is one of the earliest companies to design and soon open its own metaverse virtual store
  • Emergen Research reports that metaverse market reached $47.69 billion in 2020, by 2028 could see a revenue CAGR of 43.3%

The metaverse is everywhere, popping up in entertainment and vying for news headlines. This immersive virtual world where people live, work, shop and interact through avatars once seemed like science fiction but is fast becoming a real-world fact. Savvy companies, including Kronos Advanced Technologies (OTC: KNOS), are jumping at the chance to be part of this leading-edge innovation.

Kronos Advanced Technologies Inc. (OTC: KNOS) develops and sells a variety of disruptive, advanced, state-of-the-art air filtration and purification systems that fully remove harmful allergens, bacteria, viruses (including the flu), and even gasses from indoor breathing spaces, including healthcare and other settings.

Kronos’ own patented medical-grade technology is tested as the most effective clean air solution on the market. Kronos filters particles down to .0146 micron (.0146μm) – far beyond the 3 microns (0.3μm) of a traditional HEPA filter. Kronos® not only collects but destroys air pollutants. Kronos® AIR 5G® Air Purifiers use about 30,000 volts inside to actively destroy 99.99% of all airborne bacteria, mold, and virus particles.

Kronos® devices operate silently using nanotechnology to remove 100% of pollutants in a 400ft2 room (up to the whole house) and replenishes the room with pure, clean air every 15 minutes. Indoor household air is often four times more polluted than outdoor air, and Kronos air purifiers act like bionic lungs for the home and protect the people in it.

Unlike traditional HEPA systems that collect pollutants on filters which can, over time, grow mold and bacteria, Kronos’ patented technology destroys and eliminates all manner of harmful particles and deposits them on easy-to-clean collecting plates. This reduces the risk of harmful particles in the air and eliminates the need to replace costly HEPA filters every month.

The Kronos® AIR 5G® Air Purifier destroys and eliminates dust, allergens, bacteria, and even viruses. The AIR 5G® has been third party lab tested and confirmed to kill 99.87% of influenza virus in one hour.

The patented system’s five step process starts with a pre-filter screen that filters and collects hair, pet dander, etc. The air is then pulled through emitter wires which create a 30,000-volt electro field that zaps dangerous particulates. In the ionic field, charged particles are destroyed, killing bacteria and pathogens. The particles are then captured on collecting plates, removing dangerous toxins from circulation. The collecting plate is easily cleaned and reused without buying new filters. The catalytic layer is the final step in the purification process, removing odors and keeping the air fresh and pure. The AIR 5G® has Smart Control Auto Mode, which measures and displays the air quality in the room and self-adjusts fan speed based on how dirty the air is in the room. There’s also an AIR 5G® Smart App that displays the real time Air Quality Index and acts as a remote control.

The Kronos® AIR 5G® Air Purifier is offered in three models:

  • Kronos® AIR 5G® X3 air purifier combines powerful patented TPA® technology with a compact form factor up to six times smaller than other air purifiers, with washable and reusable filters.
  • Kronos® AIR 5G® X5 thoroughly wipes out dust, smoke, dander, bacteria, pollen, viruses, odors, germs, and more from the air, delivering the healthiest breathable air possible. It was developed for some of the world’s most polluted areas and is now available for use in the home. It runs completely silently, passing through five stages of purification to guarantee the cleanest possible air in homes or offices.
  • Kronos® AIR 5G® X8 delivers maximum power, more than doubling the capacity and efficiency of the Kronos X5, with CADR speeds of up to 470 CFM – enough to clean a 1,000ft2 room in just 20 minutes.

Kronos also offers the Kronos Car Air Purifier, the most advanced car air purifier with Kronos’ patented TPA® technology, and FitAir, the best personal air purifying solution that brings clean air anywhere by cleaning within 25ft2 of personal space at an airflow rate of 3x per hour.

Market Overview

The global air purifier market was valued at $10.38 billion in 2020 and is expected to reach $21.15 billion by 2027, achieving a CAGR of 10.7% over the forecast period, according to Brandessence Market Research. The market is primarily driven by the increasing concerns about both outdoor and indoor air pollution, coupled with the associated health problems.

Air pollution is one of the most prevalent concerns, due to worsening environmental condition. According to Health Effect Institute, it accounts for 4.9 million to 8.8 million deaths worldwide each year. Furthermore, as most of our time is spent is indoors, indoor air pollution remains a serious concern to individuals, as well as regulatory agencies. Particles like PM 2.5 can enter indoors through a wide range of sources including car engines, fireplaces, and coal- or natural gas and the infiltration of ambient particulates in urban areas. Even in the absence of solid fuels, indoor ventilation can build up PM 2.5 particles to a greater extent than in outdoor environments. Growing demand for portable air purification filters and systems in urban areas, increased advancements to catch key particulates like coronavirus, and increased regulatory measures to ensure safe environments for professionals in the industrial sector remain leading drivers of growth in the air purifier market.

Poor indoor air quality can cause fatigue, headache, and irritation of the eyes, throat, lungs, and nose, which can have a negative impact on worker productivity. Some air contaminants can cause asthma and other respiratory diseases.

Air purifier adoption is increasing rapidly in the U.S. to minimize health issues caused by poor air quality. Strict air quality standards, guidelines, and regulations in the U.S. are expected to have a positive impact on the market. For instance, the New Jersey Indoor Air Quality standard, NJAC 12:100-13 (2007), sets guidelines and standards related to indoor air quality during working hours in public employee-occupied buildings.

Key manufacturers are focusing on acquisitions and mergers to expand their geographical reach and strengthen their position in the market.

Management Team

Michael Rubinov, President and Head of Business Development

A seasoned hi-tech executive with 25 years of global business experience, Mr. Rubinov has served in various positions in sales, marketing, channel development and partner management. He has worked for large and global organizations such as Intel, NICE Systems, and Boeing (Defense and Security), as well as for start-up companies like Dialogic and Remunera International SA. He was appointed President and Head of Business Development of Kronos Advanced Technologies Inc. in February 2020. Mr. Rubinov holds an MBA, an MS Computer Sciences, and a BS Electrical Engineering.

Joseph L. Florence, Chief Operational Officer & CTO

A dynamic skilled leader in all aspects of business formation, evaluation, and execution, Mr. Florence brings a unique combination of Fortune 100 company experience with a lifetime of entrepreneurial experience to the Kronos team. He is a gifted visionary, possessing the unique ability to see future opportunities and make timely strategic adjustments and is naturally gifted at seeing unrecognized risk and overlooked opportunities. Mr. Florence has a proven track record of transforming companies to better align people, processes, and technologies to meet strategic goals and business metrics resulting in increased market share and profitability.

Kronos Advanced Technologies Inc. (OTC: KNOS), closed Friday's trading session at $0.0149, up 33.0357%, on 289,327 volume with 26 trades. The average volume for the last 3 months is 289,327 and the stock's 52-week low/high is $0.0101/$0.08115.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF).

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of renewable natural gas (“RNG”), waste-to-energy, and related infrastructure projects. “Using RNG solves multiple problems our world faces today, namely reducing emissions and responsibly disposing of waste that otherwise would pollute the atmosphere…. Compared to fossil fuels, renewable compressed natural gas can slash carbon dioxide emissions by 50%,” a recent article reads. “Fact is that while electric vehicles may get all the headlines, RNG is quietly gathering plenty of momentum on its own by creating energy from decomposing organic waste from landfills, food, agriculture, and even wastewater treatment plants. EverGen is executing an aggressive growth strategy to capitalize on the RNG trend. The company has made three acquisitions already to cement its position in the market and owns the first producing RNG facility in Western Canada through its Fraser Valley Biogas project (‘FVB’). In addition to FVB, EverGen operates two other facilities through its acquired subsidiaries: Net Zero Waste Abbotsford Inc. (‘NZWA’) and Sea to Sky Soils and Composting Inc. (‘SSS’)… [In March], EverGen made its initial foray into Alberta….” To view the full article, visit https://ibn.fm/4nuq9

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQB: EVGIF), closed Friday's trading session at $3.14, even for the day. The average volume for the last 3 months is 1,200 and the stock's 52-week low/high is $2.78/$4.21.

Recent News

Nowigence Inc.

The QualityStocks Daily Newsletter would like to spotlight Nowigence Inc.

Nowigence shines in knowledge management, a category Gartner Inc. forecasts will be one of the top five use case categories for AI software spending in 2022. “The company’s Pluaris offering is a personal knowledge management (‘PKM’) tool that generates an annotated data feed based on topics of interest and then automatically creates a permanent personal knowledge base from a specified feed and private uploads. The app works around the clock and can analyze hundreds of pages of text almost instantly,” a recent article reads. “With its Pluaris offering, Nowigence provides a unique solution to the growing challenge of collaboration overload and the desperate need for tools that identify, organize and distribute information in a uniform way so that everyone has access to critical information. Pluaris reads and analyzes articles, documents and other textual data, so users can learn more in less time, uncover hidden insights, and stay on top of the information they need to know. By integrating state-of-the-art data-processing techniques in an intuitive interface at an affordable subscription price, Pluaris allows and supports collaboration in the most efficient and effective way possible.” To view the full article, visit https://ibn.fm/otxol

Nowigence Inc. is a fast-growing SaaS (Software-as-a-Service) company that develops and sells a ready-to-use artificial intelligence (AI) platform called Pluaris™ that automates reading and analysis of textual data. Individuals, teams, and enterprises can now quickly distill knowledge buried in narrative-intensive documents instantaneously from various data sources, both public and private.

Pluaris is created for those who want to read more in less time. It is a Personal Knowledge Management (PKM) tool that generates an annotated data feed based on your topics of interest and automatically creates a permanent personal knowledge base from your feed and private uploads. It has human-like capabilities for comprehending textual data. It summarizes, provides precise answers to questions asked, analyzes different data perspectives, discovers new connections, creates organized nested notes, and allows teams to work collaboratively by sharing in real-time from anywhere in the world to draw informed conclusions.

By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Nowigence puts the power of data science in the hands of consumers. It helps individuals, teams, and organizations to quickly build expertise on one or multiple topics by generating a trove of critical information.

Nowigence targets two user types that rely heavily on fast and accurate research as primary adopters of the Pluaris platform. The first is knowledge workers of all kinds – anyone whose job is to “think for a living” like marketing professionals, researchers, legal professionals, academics, journalists, editors, scientists, and other professionals. The second are individual users who are life-long learners, hobbyists, and enthusiasts of all stripes.

Rather than spending time reading information to gain knowledge from one source at a time, users of Pluaris can gain knowledge from hundreds or thousands of sources in seconds. Keyword-based search-and-retrieval applications don’t open documents, nor read their content, nor extract key points, conduct cause and effect analysis or answer questions specifically. Pluaris includes all those features and goes one step further, with its semantic capabilities to empower users with interpretations of retrieved information. Nowigence estimates this feature alone can save typical researchers between one and three hours per workday. The platform also reduces “noise” by extracting only important and relevant information on every topic being monitored or researched. This helps cut down on information overload, a major source of workplace stress.

Pluaris Builds Intelligence

The Problem

In the modern world, virtually everyone needs to consume a tremendous amount of text-based information, in both our personal and professional lives, but doing so is exceptionally challenging because of:

  • Information Overload: For virtually any significant topic of interest, the amount of textual information available and continually generated is vastly more than can be consumed by an individual.
  • Pervasive Distractions: Thanks to modern technology, we are constantly bombarded with new inputs (e-mails, instant messages, social media, and more) reducing our attention span, leading all too often to TL;DR (Too Long, Didn’t Read).
  • Highly Imperfect Human Recall: The information that we do find time to read is easily forgotten. Even if we retain some of the key insights, the details are almost certainly lost.

Even when working in teams, we often end up researching the same content as our colleagues, and too much of the information acquired by one individual is lost in translation with the communication process to others.

Pluaris

Nowigence has worked with stalwarts and pioneers in the fields of Machine Learning (ML) and Natural Language Processing (NLP) from its early days. The company was keen to solve the big problem of the information age – too much data exists and cannot be processed manually.

Pluaris is designed to be used by regular people from day one with no need for extensive training. The platform is used across different functions and sectors, adapting to clients’ ever-changing needs. Its state-of-the-art no code editing gives organizations the flexibility to improve and tailor their results without hiring data scientists, and real time information retrieval ensures the client never misses any piece of intelligence.

Pluaris adapts to the unique needs by which individuals absorb knowledge. It doesn’t impose structured or rigid methodology. Real time operation means that Pluaris will deliver outputs instantaneously with a click.

A Nowigence team of experts spent three years training Pluaris to understand the context of every sentence it reads. If Pluaris does make an error in contextual interpretation, the user can correct it, which will instantly give the correction precedence over the ML’s algorithmic outputs. This takes away the biggest criticism against AI/ML platforms, that annotating (labeling) data and developing training datasets to build models takes too much time and effort from internal teams.

Use Cases

I need to stay on top of the latest news for my industry. Pluaris automatically retrieves and analyzes news on your topics of interest every day, so you can quickly scroll through an annotated news feed on your phone, tablet or laptop, while finishing your morning coffee.

Example: A Pluaris enterprise customer was interested in tracking news and events in the telecom industry. Nowigence was able to quickly create and then fine-tune a list of topics to monitor. In less than a week, they had an annotated news feed covering the telecom industry available to their team.

I have to come up to speed on a new topic as quickly as possible. Upload a few related websites and documents to Pluaris and within minutes you are exploring this new area of interest, scanning the summaries, gaining new insights about this topic, and finding new keywords to broaden your search and deepen your understanding.

Example: A customer who was already using Pluaris for business intelligence decided to use his account to make improvements in his health after he received a report from his doctor of a high fasting blood sugar level.

  • He uploaded a few research reports to Pluaris, read through the summaries, and explored the annotated labels. Based on that analysis, he set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.”
  • From those results, he built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level back down.

I want to be able to access the information I’ve read in the past and synthesize it with my current understanding. As you continue to add more and more information to the system over time, Pluaris never forgets. You are building a knowledge base of the information that is most relevant to you.

Example: A Pluaris user at one of the world’s largest aluminum mining companies was tasked with preparing talking points for her manager for an upcoming investor meeting. Over time using Pluaris, she had built a database of documents, including transcripts, notes, Q&A sessions, speeches, annual reports, and internal documents, some of which were from previous investor meetings. She was able to quickly explore that database through the Pluaris Dashboard and using various filters. She then pulled this information together in a Pluaris Notebook and shared that note directly with her boss.

Market Outlook

Pluaris users include:

  • Knowledge WorkersGartner estimates there are more than 1 billion worldwide as of December 2019.
  • Students in Higher Education: ICEF estimates there are 250 million worldwide as of 2020. This is Nowigence’s initial target group from a market penetration perspective.
  • Personal/Home Use: Statista estimates there are 4.7 billion active internet users worldwide as of January 2021.

Nowigence offers tiered pricing, starting at $10/month/user for individuals, while team and enterprise users, who have access to more features to facilitate collaboration and integrations to other enterprise tools, start at $45/month/user.

As a result, the Total Available Market (TAM) is more than a billion users and over $1 trillion. The Market Opportunity (the Serviceable Obtainable Market or SOM) for Nowigence is $11 billion in the combined PKM and Cognitive Computing space defined by Pluaris.

This market is growing rapidly too. The Cognitive Computing market alone was valued at $8.87 billion in 2018 and is projected to reach a value of $87.39 billion by 2026, growing at a CAGR of 31.6% from 2019 to 2026, according to Allied Market Research.

Nowigence offers differentiated value compared to other Personal Knowledge Management (PKM) tools, which have reached as many as 250 million users (Evernote) and have shown rapid adoption (Roam Research reached 60,000 users and $1 million ARR within 6 weeks of launching paid plans). Unlike Pluaris, these tools do not automatically monitor public or private sources to add to your knowledge base, nor do they provide summaries or extract intelligence. Pluaris differs from search engines as well, in that search engines do not access or store personal knowledge, and they also do not summarize or extract intelligence.

Management Team

Anoop Bhatia is the founder and CEO of Nowigence Inc., where he has worked full-time since 2015. Previously, he worked as a global operation strategic transformation leader for Momentive Performance Material (formerly GE Silicones). He has worked for over two decades in various General Electric companies across different countries, including the U.S., India, The Netherlands and Germany. He played a key role in establishing GE Silicones as the first-ever wholly owned foreign subsidiary established in India in 1996. He received his Bachelor of Engineering in Chemical Engineering from BITS in India and did his post-graduate studies in management from Heriot-Watt at Edinburgh in Scotland.

Gordon Haupt is the Chief Technology Officer at Nowigence. He has more than 20 years of experience building and leading diverse engineering and operations teams, and a strong technical background in machine learning, signal processing, and statistical data analysis, including applications in speech and text, biotechnology, and computer vision. He is a named inventor on 15 issued patents and is experienced in all phases of engineering development and operations. He holds a B.S. degree in Engineering Mechanics from the University of Wisconsin and M.S. and Ph.D. degrees from Stanford University in Aeronautics and Astronautics.

David Evans is the company’s acting CFO & General Counsel. As an attorney and licensed CPA in the state of New York, he has extensive experience in multistate and international tax policies and guidelines, federal taxation laws, mergers and acquisitions, including valuation of closely held businesses. He is a contributing author to the New York State Tax Service, a six-volume publication of NYS tax laws and regulations. His prior experience includes being a Managing Director for UHY Advisors LLC, a board member and chairperson of the Tax Division Executive Committee of New York State Society of Certified Public Accountants and a past president of the Estate Planning Council of Eastern New York. He holds degrees from Hofstra University and State University of New York at Buffalo.


Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company appears poised to build upon its growth momentum to expand beyond the investor relations space to include integrated cross-organizational solutions that can be deployed across multiple departments. A recent article reads: “The company continues to go from strength to strength and has grand plans for 2022. In a recent episode of a Sequire Spotlight series called Sequire Spotlight Presents SRAX (SRAX): The Savvy Solution to Investor Relations, SRAX’s CEO Christopher Miglino revealed that the product roadmap involves expanding the portfolio to include innovative technology that can be deployed across the whole enterprise. The company appears poised to take its holistic approach beyond the investor relations space to include solutions that are more integrated into the organization, from finance to marketing. As a technology-centric company committed to building new products fast, SRAX has been working on delivering these new cutting-edge solutions to the marketplace in the months to come.” To view the full article, visit https://ibn.fm/u7wPd

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $3.91, off by 3.2178%, on 44,788 volume with 174 trades. The average volume for the last 3 months is 44,788 and the stock's 52-week low/high is $3.53/$7.29.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is helping build robust and decentralized food systems through its green ammonia production solution. The technology, which generates green ammonia from sustainable electricity, air and water, eliminates carbon dioxide emissions linked to the industrial production of anhydrous grey ammonia. The system also reduces the agricultural sector’s carbon footprint related to fertilizer production and distribution – the sector uses about 80% of the ammonia produced annually to satisfy its fertilizer needs. “In addition to reducing CO2 emissions, the FuelPositive system decentralizes ammonia production, freeing farmers from supply chain shocks, as is the case currently. In fact, a case study conducted last year revealed that the cost of green ammonia production using the company’s system was about CA$560 per metric ton compared to the then average landing cost of CA$900 per metric ton of grey ammonia – about 37.8% cheaper,” a recent article reads. “According to FuelPositive, the landing cost of grey anhydrous ammonia to farmers in Manitoba, Canada, had doubled from CA$600 to more than CA$1,200 per metric ton in just six months, further demonstrating the extent of the fluctuations. Current pricing per delivered metric ton of anhydrous ammonia in Manitoba is well over CA$2,000. The case study, the company observed, showed that its system offers independence from the widely fluctuating supply chain, a benefit that holds especially true given the current conflict-induced disruptions.” To view the full article, visit https://ibn.fm/bwskc

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday's trading session at $0.14, off by 2.2346%, on 95,311 volume with 26 trades. The average volume for the last 3 months is 95,311 and the stock's 52-week low/high is $0.09/$0.3105.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

  • The global cryptocurrency market is expected to grow at a CAGR of 12.8%, to reach US $4.94 billion by 2030
  • The increase in cryptocurrency adoption worldwide has shown explosive market growth and the increased need for transaction facilitation like LQwD’s PaaS protocol on the Lightning Network
  • India ranks number two in the adoption and use of cryptocurrency
  • Experts in the cryptocurrency industry estimate that India has more than 20 million crypto investors, with most growth being driven by users under the age of 35
  • LQwD currently has 10 active nodes on the Lightning Network with a capacity of over 10 BTC and global coverage for faster transactions and lower fees

In 2020, the global cryptocurrency market was valued at US $1.49 billion. This number is expected to grow at a CAGR of 12.8% from 2021 to 2030, resulting in a projected value of US $4.94 billion (https://ccw.fm/uN8fO). The growing adoption of cryptocurrency as legal tender around the world is nurturing the market increase, with the United States, El Salvador, India, and China showing remarkable growth. Among the different types of cryptocurrencies circulating, Bitcoin remains one of the more popular selections. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, participated in the recently concluded NobleCon18 – Noble Capital Markets’ 18th Annual Investor Conference that took place at the Hard Rock Hotel, Hollywood, Florida. “Bitcoin’s Lightning Network is continuing to see explosive growth. LQwD is benefiting from this growth as we continue to strategically expand our Lightning Network presence through the launch of our global routing nodes to become one of the largest payments facilitators on the network,” LQwD CEO Shone Anstey commented before the event. According to a recent article, LQwD launched its platform-as-a-service (“PaaS”) on the Lightning Network in November 2021. Since then, the company has launched multiple nodes worldwide – U.S., Ireland, Germany, Indonesia, Italy, Singapore, Sweden, England, France, and India. Presently, the company is using its Bitcoin reserve for the advancement of the Lightning Network and PaaS solution. To view the full article, visit https://ccw.fm/fGSGk

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Friday's trading session at $0.1165, off by 5.515%, on 26,655 volume with 13 trades. The average volume for the last 3 months is 26,655 and the stock's 52-week low/high is $0.10/$4.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.